1. Home
  2. CUE vs CMTL Comparison

CUE vs CMTL Comparison

Compare CUE & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.49

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$3.33

Market Cap

64.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
CMTL
Founded
2014
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
49.6M
64.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CUE
CMTL
Price
$0.49
$3.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$6.00
AVG Volume (30 Days)
390.5K
189.1K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,100,000.00
$499,528,000.00
Revenue This Year
$36.58
N/A
Revenue Next Year
$32.10
$5.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$1.19
52 Week High
$1.75
$4.88

Technical Indicators

Market Signals
Indicator
CUE
CMTL
Relative Strength Index (RSI) 30.51 56.41
Support Level $0.47 $3.17
Resistance Level $0.51 $3.73
Average True Range (ATR) 0.04 0.23
MACD -0.00 0.03
Stochastic Oscillator 9.40 59.44

Price Performance

Historical Comparison
CUE
CMTL

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

Share on Social Networks: